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Abstract 
CELL-MEDIATED CYTOTOXICITY OF 
JENSEN TUMOR IN SPRAGL.JE~DAWI~EY RA.TS 
by Theodore D. Masek 
An in v~tro system for the study of the cell-mediated 
immune response to Jensen Sarcoma (,JS) is described. 'I1he 
tumor grew unrestricted and lead to the demise of 80% of 
successfully challenged Sprague-Dawley rats (persistors) 
while 20% of challenged rats (regressors) destroyed the 
tumor by an unknovm mechanism(s).. Lymphocytes from both 
persistors and regressors were shown to be cytotoxic for 
tumor cells in vitro,. Pretreatment of tumor tar9et cells 
with "immune" serum from persistors or regressors had no 
ef feet on the in· vitro cytotoxici ty of .lymphocytes from 
tumor-challenged rats. Pretreatment of lymphocytes with 
irmnune serum, however, was shown to reduce the ·in· vitro 
cytotoxicity of uirmnune" lymphocytes although the effect 
was variable and did not correlate well with the in vivo 
tumor status. Lymphocyte stimulation wi.t.h Phytohemmag-glu-
tinin (PHA, a T cell mitogen) was decreased in persister 
rats; while Poke Weed mitogen (PWM; a B cell mitogen) 
stimulation was increased in persister rats. Treatment of 
"immune" lymph.ocytes with a) supernata.nts from tumor cell 
cultures, b) irradiated tumor cells or c) sonicated tumor 
cells did not result in increased DNA. synthesis. The 
advantages of the Jensen sarcoma system as a model to 
study the mechanisms of cell-mediated immunity are discussed., 
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Immunology began as investigators started to study 
the mechanisms involved in the ability.of a host to resist 
noxious agents or invasive organismso The reactions 
involved were the result of previous exposure to the same 
agent or organism and dealt mainly with antibody-mediated 
protection.. Cell-mediated immunity .is the recently studied 
branch of immunology that investigates inunune reactions 
mediated by cells.. Cell-mediated immune (CMI) reactions 
·involve t:r;ansplant.ation immunity, tumor immunity, immunity 
to microorganisms and certain fungi and possibly certain 
autoimmune diseases,, 
Among the first workers to report the foreign tissue 
rejection phenomenon were Bashford, Murray and Haaland (4) 
in 1908 and Russell (47) in 1912. These workers reported 
that a mouse tumor transplanted to a rat would survive for 
8 days before dying. If the tumor were transplanted back 
to the mouse before eight days, it would continue to live~ 
If this tumor were again transplanted back to the same 
rat, it would be rejected at an accelerated rate. Murphy 
(36-38) in 1912-1914, found that Rous sarcoma, would grow 
in .immunoincornpetent duck or pigeon embryos but not in 
immunocornpetent adult animals and that the tumor growth 
could be reversed if adult lymphoid cells were inoculated 
with the tumor .. 
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Most investigators at that time a.greed that antibodies 
were responsible for all forms of immun.i ty. It was known 
that immunity to microorganisms could be passively trans-
ferred using irmnune serum~ Since irn.muni ty to grafted tissue 
could not be transferred using serum this phenomenon was 
not considered to involve the immune system. However, 
Porter (40) in 1930, Mitchison (3~) in 1954, and Billingham 
(5), also in 1954, all succeeded in transferring passive 
immunity to certain tumors with immune lymphoid cells but 
not with immune serums 
In the late 1940's Medawar (30-33) demonstrated that 
human skin grafts would be rejected at an accelerated rate if 
the recipient had previously received a graft from the same 
donor. The mechanism(s) of these reactions rem~ined 
unclear until the classical work of Weaver, Algire and 
Prehn (49) in 1955. These investigators demonstrated that 
lymphocytes mediated tissue rejection. Their experiment 
used chambers containing homologous or allogeneic tissue 
enclosed by millipore membranes and placed within the 
peritoneal cavity of mice. Membranes of two pore sizes 
~ere used; one was small enough to exclude cells but not 
antibodies and the other allowed cells to pass~ After 
seven days within the animal the tissue within the small 
pore chamber was intact while the tissue within the large 
pore chamber was destroyed by infiltratinq: lymphoid cells. 
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As can be seen in the examples above, cell-mediated 
immunity has developed hand in hand with tumor immunology. 
The similarities are not only historical. Evidence now 
strongly suggests that tumor reje·:::tion is mediated by the 
same reactions as allograft rejection (19). The role of 
lymphocytes as mediators of tumor rejection has been 
demonstrated beyond a reasonable doubt by tissue culture 
experiments (l,6,29,43). Data have been presented which 
indicate that macrophages play a role in allograft rejection 
and possibly tumor rejection (10). 
This concept t.hat tumor rejection was indeed an 
immunological response mediated by the cel.lula.r arm of the 
immune system led investigators to hypothesizf=. that cancer 
is· a disease sequential to immunological derangement. Even 
at the turn of this century workers were trying to develop · 
methods of tumor im.rn.unization. Unfortunab:~ly many of these 
studies confused tumor specific antigens (TSA) with normal 
transplantation antigens. It was not until the development 
of inbred animal strains that TSA could be proven to exist. 
Gross in 1943 (12), Foley in 1953(7), and Prehn and Main 
in 1957 (41) all presented evidence that TSA did exist. In 
the experiments of Prehn and Main tumors were induced by 
methylcholanthrene (MCA) which were then transplanted to 
syngeneic mice and allowed to form palpable nodules. If 
the tumor were surgically removed, the animal would be more 
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resistant to a second tumor transplant when compared with 
the control. Normal tissue did not sensitize animals against 
tumor growth even when it was derived from the same mouse in 
which the tumor originated. Mice which were resistant to 
tumor challenge did not reject a skin graft from th~ animal 
in which the tumor was derived. It was concluded that MCA 
induced tumors carried TSA. Since this classical experiment 
TSA have been demonstrated in other tumor models. 
In the last 25 years there has been a rapid increase 
in information concerning the mechanisms involved in 
cellular immunology; however, the exact involvement of such 
aspects as soluble mediators, antibodies and other humeral 
factors remains unclearo Most investigators accept that 
close contact between immune cells and their targets is a 
prerequisite before detectable cytopathic changes occur 
(8,9,35,42,50). The mechanism of cytotoxicity after 
attachment is vague. 
Gorer (9) in 1956 and Karush and Eisen (27) in 1962 
proposed that the cytotoxic effect of immune cells is due to. 
small amounts of antibodies by which they adhere to as well 
as destroy their targets. This ~ypothesis explains the 
specificity of lymphocyte-mediated immune reactions. The 
theory does not explain, however, how these cytotoxic 
reactions may be carried out in the absence of complement 
which is required for antibody cytolysis nor does it explain 
5 
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the cytotoxic effect seen when phytohernagglutinin {PHA) 
treated nonimmune, allogeneicr or syngeneic lymphocytes are 
plated with target cells. 
The allogeneic inhibition hypothesis of the Hellstroms 
(13-18), was based on the observations of Snell (48), made 
in 1961, that a homozygous mouse tumor would not grow as well 
in Fi mice as it would in the parental strain. It was 
postulated that destruction of a target cell was caused by 
contact between the lymphocyte and target cell where 
surface structure differed in the two cell typeso Lympho-
cytes are given a secondary role in cytotoxicity. Only 
structural differences between two cells is necessary for 
cytotoxicity i.e. two fibroblasts, each from a separate 
allogeneic animal, should have the capability of destroying 
each other. This theory has several distinct drawbacks~ 
The hypothesis does not satisfactorily explain how syngeneic 
lymphocytes can kill tumor cells which possess only TSA. 
Holm and Perlmann (23-26) demonstrated that mixtures of 
allogeneic, syngeneic and xenogeneic fibroblasts did not 
result in cell damage and that heat-killed lymphocytes were 
shown to exert no cytotoxic effect on target cells~ This 
theory cannot explain the observation that parental skin 
grafts on Fi hybrids were not rejected. 
According to a third theory, cell destruction by 
immune lymphocytes and macrophages is caused by the release 
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of a soluble toxic factor { s) from t.he immune lymphocyte 
upon contact with the target cell (44-46). 
(11) in 1968 and Kramer and Granger (28) in 
Granger and Kolb 
1972 have 
presented experimental evidence in favor of this hypothesis. 
The data suggest that toxicity from a soluble factor(s) is 
nonspecific after release. Attempts at finding soluble 
factors in the supernatant of target cell cultures killed 
by sensitized lymphocytes have not been successful in many 
systems. The scientists who propose this theory explain 
that these soluble factors are probably deposited at high 
concentrations at the appropriate site by specific immune 
contact between antigen and lymphocytee These factors are 
als6 thought to remain bound to cell membranes not allowing 
them to be assayed" 'J:lhis theory explains immune specificity, 
surveillance of tumors and cytolysis of target cells without 
serious drawbacks. These theories, however, may not be 
mutually exclusive and ma.y overlap in the in vivo situation. 
In some current research, scientists are investigating 
so called "blocking factor". 1'hese factor (s) found in the 
serum of tumor bearing animals have the capacity to block 
lymphocyte-mediated cytolysis by co~ting the target 
cell (20-22) . Baldwin has demonstrated in a rat hepatorna 
model that factors in serum will block cytolysis by coating 
the lymphocytes., He has named this "inhibition factor" (2,3). 
Whether or not this blocking is immunologically specific 
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remains to be clarified. Conflicting data has been presented 
in this regard. There is, however, the hypothesis that the 
cellular arm of the immune system i.s·in some way modified or 
controlled by humeral factors in the serume 
An understanding of the mechanism(s) involved in 
allograft and tumor rejection is fundamenta.l to the 
elucidation of the processes involved in tumor escape from 
the host surveillance system. One problem in the study of 
cell-mediated reactions is in finding a model that allows 
easy in vitro study of these reactions. The confusion in 
the first part of this century between TSA and normal 
transplantation antigens has led many investigators to use 
only syngeneic tumor systems (tumor systems that have 
arisen in inbred lines and are maintained in inbred lines) 
in immunological studies. It is the authors opinion that 
all immunization experiments dealing with protection against 
tumors should use these models. However, in order to stu.dy 
the exact lymphocyte-target.cell mechanisms involved in tumor 
cell lysis, other tumor models that react more strongly to 
tumor or allografts should be considered. Since allograft 
and tumor rejection are mediated by the same reactions, 
allogeneic tumor systems (tumor systems in which the tumors 
are developed in one strain but are maintained in a 
different strain) may be of use in studies of mechanisms. 
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It is the goal of this thesis to ir1troduce the Jensen 
tumor model as a system to investigate the mechanisms(s) of 
tumor and allograft rejection. 
INTRODUCTION 
Cell-mediated im..111unity is thou9ht to play a major 
role in tumor rejection ig vivo (14) o Lymphocytes from 
tumor bearing animals have been shown to be cytotoxic for 
that tumor in vitro, demonstrated by ei tJ1er colony 
inhibition, microcytotoxicity tests or radioisotope 
release techniques (9,10,13,22). The role of humeral 
factors in tumor immunity is less clear, although it is 
thought that cell-mediated immunity may be modified by 
soluble factors found in the serum. 
An understanding of the mechanism(s) involved in 
tumor immunity is fundamental to the elucidation of the 
processes involved in tumor escape from the host surveillance 
system. An association between blastogenesis and the rapid 
in vitro destruction of L cells by FHA-stimulated lymphocytes 
has been reported (5,6). Stulting, Todd and Amos (21) have 
recently demonstrated that the integrity of the target cell 
membrane is necessary.for lymphocyte attachmente Blasto-
genesis results only after attachment to specific antigens 
or stimulation by non-specific mitogens such as PHA or PWM. 
Jensen Sarcoma is rapidly growing undifferentiated 
pleomorphus-cell tumor which originated in an outbred gray 
rat that had been inoculated with an acid-fast bacillus in 
O.Ce Jensen's laboratory in 1907e Although termed a 
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sarcoma, Jensen tumor cannot be classified as either a 
carcinoma or sarcoma.. In tumor challengF.!d Wis tar or 
Sprague-Dawley rats tumor growth is established in 90% but 
not demonstrated in the remainder; ·of the 90% which show 
tumor growth 80% e'"<rentually succumb to the tumor and 20% 
regress spontaneously. The Jensen system has been used as 
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·a model to study tlLTUOr cell sensitivity to radiation (19), 
metabolic changes of the tumor cell after exposure to 
x-rays (15), and the effects of cortisone and insulin on 
tumor weight (16) .. The Jensen tumor has also been used to 
study carbon dioxide metabolism (18}. The host immune 
responses toward Jensen sarcoma have not been investigated5 
· The purpose of this work is to measure the capability 
of lymphocytes from animals in which the tumor spontaneously 
regressed (the regressors) and animals in which the growth 
of the tumor resulted in the animal;s death (the persistors) 
to mediate in vitro cytotoxicity to tumor cells and to study 
the correlation of blastogenesis and tumor growthe The 
following questions are asked: 1) When and to what degree 
can lymphocyte-mediated cytotoxicity be demonstrated in 
regressors and persistors? 2) Will.sera from rats in which 
the tumor has regressed or in which the tumor is actively 
growing affect lymphocyte-mediated cytotoxicity? 3) Is 
there an association between lymphocyte blastogenesis and 
tumor destruction? 
Ml'.1 .. TERIA.L AND METHODS 
Animals and In Vivo Tumor.. M.ale Sprague-Dawley rats 
(350-400 gms., Holtzman Co., Madison Wisconsin) used in this 
study were maintained under standard laboratory conditions. 
Animals which had received an I.P. inject.ion of 5 x 10 6 
Jensen tumor cells 7 days previously were sacrificed and 
the tumor mass removed aseptically o ,Jensen cells produced 
tumor more consistently and rapidly in the muscles of 
experimental animals if they were conditioned by a passage 
·in vivo (I. P. ) . 1rhe tumor was minced and teased to release 
individual cells, suspended in Hanks Balanced Salt Solution 
(HBSS) and strained through sterile gauze to remove large 
fragmentso Experi~ental animals were inoculated I.Me with 
lGO x 107 Jensen tumor cells in the righi thigh~ 
Jensen Tumor Mainten·ance. Jensen tumor cultures 
originally obtained from R .. E. Beltz (Lorna Linda University, 
Lorna Linda, Cae) were maintained in our laboratory under· 
standard in vitro conditions. The original culture was 
maintained in plastic tissue culture flasks (Falcon 
Plastics, Los Angeles, Ca.)~ When sufficient numbers of 
cells were available, 1.0 ml samples containing 1.0 x 106 
cells in 7% dimethyl sulfoxide were frozen and stored at 
-60 C. All Jensen tumor cells used in experiments were 
utilized within 20 in vitro passages. 
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Cell Culture and Medium. C~ll culture medium 
utilized in routine cell culture and experiments consisted 
of RPMI 1640 (Grand Island Biological Co., Grand Island, 
New York) supplemented with 10 percent fetal calf serum (FCS) , 
• 
100 u/ml pencillin and 100 J\.g/ml streptomycin. Conditioned 
medium (CM) which was used in microass~ys consisted of 45% 
fresh media, 45% media from 24-48 hour Jensen tumor cell 
cultures and 10% FCS~ Cell cultures were maintained in 
sealed 250 ml plastic flasks incubated at 37 C. The 
cultures were passed twice weekly or when the monolayers 
became 90 - 95% confluent. 
Lymphocyte Separation. A Ficoll-Hypague density 
gradient centrifugation, separated lymphocytes from whole 
heparinized blood (50 u /ml) which had been obtained by 
cardiac puncture (17,3). A 2.0 ml aliquot of whole blood 
was diluted 1:3 in 0.15 M saline and layered onto 3.0 ml of 
Ficoll-Hypaque. After centrifugation at 400 x g for 40 min. 
i.n a Sorvall GLC-2 centrifuge, the purified lymphocytes were 
collected by aspiration from the aqueous Ficoll-Hypaque 
interface. The lymphocytes were washed 2X in HBSS, a 
viable count was performed using a hemacytometer and the 
cells finally resuspended at a final concentration of 
5 x 10 5 per ml. 
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Cell-Mediated _Cytotoxici 1:-.Y_ 'T~st., Lymphocyte in vitro 
cytotoxicity was assayed by a modification of the method 
described by Hellstrom et al. (12). Fifty to 100 target 
cells in 0.2 ml CM were plated in Falcon Microtest II 
plates (Falcon Plastics Coe, Los Angeles, California) and 
incubat~d for 24 hr at 37 C to allow target cell attachmente 
Subsequent to this the medium was decanted and replaced 
with Oa2 ml of fresh medium containing 0.25 x 105, 0.5 x 105· 
and leO x 105 lymphocytes from experimenta~ or control 
nonchallenged animals and the cultures incubated further for 
two days., The cultures we:r.e then w·ashed two times with 0. 2 ml 
HBSS, fixed for 30 minutes with absolute methanol, staihed 
with Giemsa stain and the remaining cells counted under an 
inverted microscope. The mean number of attached cells in 
wells incubated with experimental lymphocytes was compared 
with the mean number of attached cells in wells cultured 
with control lymphocytes and expressed as percent cytotoxicity 
utilizing the following expression: 
Number of cells in control wells -
% cytotoxicity = 100 x Number of cells in experimental wells 
Number of cells in control wells 
Ser1m Blocking Activity. Sera obtained from blood 
collected by cardiac puncture were tested for their ability 
to protect target cells from aggressor lymphocytes. Target 
cells were seeded into microtest pretreated plates as before. 
The medium was then replaced with 0.1 ml of a 1:5 dilution 
of heat inactivated (50 C/30 min) test serum or normal 
control serum. After 45 minutes incubation at 37 C the 
serum was removed, lymphocytes from r~~gress.ors or control 
animals were added and a cytotoxicity assay was performed 
as previously described. 
Test for Serum Inhibitory Act~v~_ty.. 'rhe method of 
Baldwin, Price and Robins (2) was used to determine the 
direct effect of "immun~" sera from tumor bearing animals 
on the cytotoxic response of immune lymphocytes. •rest and 
control heat inactivated sera were diluted 1:3 in HBSS and 
0. 3 ml ·was placed into a 0. 2 ml sample of RPMI medium 
containing· LO x 106 or O c; 5 x 106 lymphocytes from control 
or regressor animals. The mixture was then incubated at 
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37 C for 60 minutes with occasional shaking, centrifuged at 
120 x g for 5 min and the lymphocytes resuspended in 2.0 ml 
of RPMI 1640. The treated lymphocytes were tested for their 
ability to kill J"ensen tumor cells in vitro. in the standard 
cytotoxicity assay as described abovec 
·Lymphocytt:.: Transformatio·n Te~t_~ Triplicate cultures 
containing 1.0 x 106 peripheral blood lymphocytes in 0.5 ml 
RPMI 1640 medium v.rere prepared in 12 x 70 mm Falcon plastic 
culture tubes {Falcon Plastics, Los Angeles, Ca.) a Lympho-
cyte cultures were then treated with 25 .J'\ g PHA-P (DIFCO, 
15 
Detroit, Michig~n) in 0.1 ml HBSS, 1:20 dilution of Poke 
Weed Mitogen (PWM, DIF'CO), or 0 .. 1 ml HBSS only and 
incubated for 72 hours at 37 C in a CO~ incubator (National 
.w 
Appliance Co., model 3221, Portland, Oregon). Subsequent to 
this 2 C of 3H~-thymidine (specific acti.vi ty 6. 0 Ci/mmole, 
Schwarz-Mann, Orangeburg, N.Y.) was added to each culture 
and the cells incubated an additional 12 hours. Then each· 
culture was washed 3 times with cold PBS, the cells disrupted 
with lN NaOH and the nucleic acid precipitated with 5 percent 
TCAe The precipitate was collected on a 0.45 m pore size 
Millipore filter~ The incorporation of 3H-thymidine was then 
determined in a Nuclear-Chicago {Chicago, Illinois) liquid 
scintillation counter. The stirnuiation index was calculated 
as follows: 
Stimulation index = CPM in mitbgen st~mulated cultures 
CPM in unstimulated control cultures 
RESUUrs 
Kinetics of Direq_.!: Lvmp!.!_~cyte.mmediateq _ _5;_ytotoxicity of Tumor 
Challenged Animals 
Target cells were established.in Microtest II plates 
as described in the text and treated with lymphocytes 
obtained from peripheral blood just before tumor transplant 
.Cday 0) and at different days after tumor challenge. 
Titrations were performed with different effector to target 
cell (E/T) ratios to determine at what ratio the peak 
activity could be found. An E/T ratio of 2000:1 was 
demonstrated to be the ratio in which the highest cytotoxic 
activity could be found. Figure 1 represents the data from 
cytotoxicity as~ays using 3 E/T ratios, 2000:1, 1000:1 and 
500:1. At the E/T ratio of 2000:1 cytotoxicity was first 
detected between days 4 and 8 in both the regressors (15.9%) 
and persistors (10.1%) e Th~ percerit cytotoxicity peaked at 
day 21, regressors (80.4%) and persistors (78e9%), and 
remained high in those animals tested between days 30 and 40 
after tum6r challenge. Cytotoxicity could be demonstrated 
at this E/T ratio in regressors on day 100, all persistors 
died within 65 days after tumor challengee 
To test the possibility that high E/T ratios might 
mask a difference in direct cytotoxicity between regressors 
and persistors, cytotoxicity was determined at lower E/T 
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Figure 1 
Direct Cytotoxicity of effector cells from regressor and 
persistor animals. Peripheral blood lymphocytes were collected 
at various days following tumor challenge and tested in vitro 





















.EIT RATIO 2000:1 
E/T RATI0·1000:·~ 
E IT RA TIO 500: 1 
DA VS AFTER TU MOH TRANSPLANT 
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ratios. There was variability in the m~gnitude of the 
cytotoxic response at different E/T ratios. However, the 
same pattern of response was demonstrated ·and only small or· 
no differences between regressors and persistors could be 
detected. At the E/~ ratio of 1000:1 cytotoxicity was not 
demonstrated until day 14 in comparison with day 6 at 
ratio 2000:1~ The peak response was on day 20 the same as 
the E/T ratio of 2000:1 but to a lesser degree: regressors 
(42.3%) vs., (80o4%) and persistors (48.5%) vs. (78.9%) .. 
A response was also detected between days 30 and 40 in 
both regressors and p~rsistors. When the E/T ratio was 
lowered to 500 :·l a defi.ni te responst~ wc-:s demonstrated on day 
20, regressors (13.6%), persistors (18.8%) and remained 
between days 30 and 40. These data show that strong cytotoxic 
response is demonstrated in vitro regardless of tumor status 
in vivo and that the magnitude of the response is related to 
the E/T ratio and to the time after tumor challenge .. 
Effect of Serum Coated Target Cells on Direct Lymphocyte 
Cytotoxicity 
Target cells were again plated into Microtest II 
plates as described above. Sera obtained at different days 
after tumor challeng-e from normal controlsr persistors or 
regressors was added and the plates incubated for 45 minutes. 
The serum was then decanted and effector cells added. The 
results of these experiments (Table· l) demonstrate that 
TABLE 1 















Target cells were treated with sera from control, 
tumor bearing persistors or regressors as described 
in text. Cytotoxicity was determined at E/T ratio 
2000:1 
% cytotoxicity 0 day -
a% Blocking = 100 x % cytotoxicity test day 
% cytotoxic:Ct.y-0 day -
20 
serum from persistors had no effect on direct lymphocyte-
mediated cytotoxicity and that serum from regressors had 
little or no effect. 
Effect of Serum Coat.:;;d Lymphocytes or~. C~tC?toxici ty 
Baldwin, Price and R6bins have demonstrated that 
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sera from tumor bearing animals, but not regressors, can 
block lymphocyte-mediated cytotoxicity by coating the 
lymphocyte (2). To investigate the possibility that a 
similar mechanism may play a role in the J'ensen tumor model, 
effector lymphocytes were treated with serum from normal 
control, regressors or persistors obtained at different 
days after tumor chailenge. These lymphocytes were then 
added to Jensen tumor target cells in Microtest II plates 
and a standard lymphocyte-mediated cytotoxicity test 
performed as described in the text. The experiment was 
repeated a total of three times utilizing se~um from 
different animals. The data which represents a typical 
experiment can be seen in Table 2. At the E/T ratio of 
2000:1 only the persistors' serum was tested since 
previous work by other investigators has sl~own that only 
the persistors produce consistent inhib£tion throughout 
the disease (1,9). Definite inhibition activity was 
demonstrated only on day 16 ( 39 .. 0%) ~ 1'he E/'l' ratio was 
lowered to see if this effect was being masked by the lar~e 
amount of sensitized lymphocytes. At the E/T ratio of 
22 
TABLE 2 



















39 .. 0 N.T 






Lymphocytes were pretreated with sera from control, tumor 
bearing persistors or regressors as described in the text. 
Cytotoxicity was determined at E/T ratios of 2000:1 and 
1000:1 
a% Inhibition = 100 .x 
% cytotoxicity by lymphocytes 
with normal serum -
% cytotoxicity by iymphocytes 
with test serum 
treated 
treated 
_%_c_y_t_o_t-oxici ty by ly-. _m_p_h_.y_c_y_t_e_s_t_r_e_a_t_e.d 
with normal serum 
1000:1 inhibition factor was demonstrated on day 6 and 
day 20 and the percent inhibition increased to 157.4% and 
65.8% respectively~ However, even the regressors' serum 
showed 92.6% inhibition on day 16. It is evident from 
these data that inhibition factor can be demonstrated but 
that it is sporadic and does not correlate with in vivo 
tumor status. 
Lymphocyte Response to Mitogen Stimulation from Regressor, 
Persister and Control Animals 
Triplicate cultures of lymphocytes, from normal 
control, regressors or persistors were set up with and 
without mitogen. After 48 hours incubation, the cultures 
were pulse labeled for 12 hours with 3H-thymidine. The 
cultures were then harvested and the incorporation of 
3H-thymidine determined in a liquid scintillation counter. 
The results of these experiments using PHA and PWM are 
represented in Figure 2. When PWM, a B-cell stimulator, 
was used, the normal controls and regressors gave similar 
stimulation indices, 9.2± 2.0 and 12.9± 4.2 respectively. 
Persistors gave an increased response, 21.0± 9.7. Fifty 
percent of the persistors had stimulation indices above 
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the highest index found in the control whereas the other 
half fell within the normal range explaining the relatively 
high standard error. When PHA, a T-cell stimulator was 
used as the mitogen the regressors had an increased 
Figure 2 
Lymphocyte response to rnitogen stimulation from regressor, 
persister and control animals. A comparison of lymphocytes 
to incorporate 3H-thymidine after exposure to PWM (top) or 
PHA (bottom) as described in the text. The mean value of 6-8 
animals for each group is given with the standard error. 
astimulation index = CPM of cultures with mitogen 
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stimulation index (24~6± 8.8) compared with the control 
(13.6± 2.6). The persistors' index was depressed (7.0± 2.4). 
The~e data suggest that lymphocytes from·regressors and 
persistors differ in their ability to.respond to PWM and 
PHA and that these differences may be associated with tumor 
success in vivo. 
Attempts at Lymphocyte Stimulation by Various Tumor Cell 
Components 
We next designed an experiment to stimulate the cells 
with whole tumor cells, supernatant fluid or sonicated 
tumor cells to investigate whether or not stimulation 
patterns we demonstrated with mitogen were also demonstrable 
with a specific antigen(s). Table 3 presents the data 
obtained in.this experiment. All attempts at stimulation of 
lymphocytes with tumor cell components failed. 
TABLE 3 
Attempts at Lymphocyte Stimulation by Various Tumor Cell Components 
Stimulation Index1 
Target Cell/ Ir~adiatea2 
Lymphocyte Whole Cells Sonicated Tumor Cells3 Supernatant4 
Ratio· Immune Control Immune Control Immune Control 
2:1 1. 5 1. 4 .42 .1 .43 
1:5 Ll .39 .33 .21 .42 
1:10 1. 2 .67 .. 48 .21 
1:100 .80 1.. 2 .51 .1 
. cpm in lymphocyte cul ture·s with lymphocytes arid -tumor-cell 
1stimulation index = component. _____________ _ 
cpm in lymphocy'te cultures without tumor components 
2control value = 2026 ± 484 
3control value = 1832 S.E. ± 365 
4Effect of supernatants from tumor cell cultures undiluted and diluted 1:10 




Three main findings restilted from this study. First, 
the tumor cell line was shown to be immunogenic in that 
lymphocytes from ~nimals receiving tumor transplants kill 
target cells in vitro. Second, sera from neither persistors 
nor regressors will block the cytotoxic effect of sensitized 
lymphocytes. Sera will block the cytotoiic effect by 
coating lymphocytes; however, this effect is sporadic and 
does not correlate with in vivo tumor status. Third, 
persistors' lymphocytes do not respond as strongly to PHA 
stimulation as do normal control animals. Regressors had 
an increased stimulation index above that of the control 
when stimulated by PHA. 
The finding that lymphocytes are cytotoxic to tumor 
cells regardless of tumor status in vivo is in agreement 
with findings from other investigators using other tumor 
models (1,7,9). One hypothesis introduced to explain why 
tumors grow persistently ~n vivo in spite of the fact that 
they can be killed in vitro by lymphocytes from the tumor_ 
bearing animals is that the lymphocytes are inhibited 
in vivo by factors in immune seia (2,9-11). These factors 
do not appear to play a major role in tumor success in the 
I 
Jensen tumor system. When target cells were coated with 
sera from challenged animals, cytotoxicity was not altered. 
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sera from challenged animals. This inhibitory effect was, 
• , · · .. - · ~.- ·; r: .. 'l _;: . · . ·· i_ .,_. , :~. , . .- • • 
however, only in sporadic examples.in both·persistors and 
regressors. These observations on the inhibitory effect of 
sera are intriguirtgo However, it is necessary to separate· 
specific immune inhibition, nonspecific inhibition and to 
test procedural artifacts. Further studies are needed to 
answer these questions. It would be extremely helpful to 
isolate the factors from the serum and describe their 
biochemical nature. Data is still not yet available six 
years after these serum blocking factors were first 
described .. 
The Jensen tumor arose in an outbred population of 
rats (20). It is interesting to note tha~ 80 percent of the 
successfully challenged rats succumb to the tumor and die. 
The study of the mechanism(s) involved in the tumor success 
may prove useful in the elucidation of how tumors escape 
the host immune surveillance system. Further investigation 
may also give insight into the exact cytotoxic mechanism of 
allograft rejection. 
We would also like to point out! that the depressed 
T-cell function of the persistors, measured by PHA stimulation, 
may play a role in tumor success. It may be hypothesized that 
the high ratio of lymphocytes to target cells in the micro-
cytotoxicity assay may make the a.ssay more sensitive than 
3Q 
'' ; 
the in vivo situation~ bk§ b~rh~~g~ sirliilar, to "concomitant 
immunity" described by Gershon (4)~ If this factor is 
linked with a mal~unctioning T-cell population in the 
persister, the tumor may simply outrun the host immune 
system. 
The fact that sensitized lymphocytes failed to 
increase their uptake of tritiated thymidine when exposed to 
irradiated cells, sonicated tumor cells or supernatant may 
be explained in llght of the recent findings of Stulting, 
Todd, and Amos (21). They demonstrated that sensitized 
lymphocytes directed against allogenic antigens recognize 
and bind to an antigenic complex whose organization is 
dependent upon the.integrity of the target cell membrane. 
j . 
It is possible that.the lensen tumor antigen is a complex 
whose organization is dependent upon the integrity of the 
target cell membrane. Thus, the antigen would not be 
released into the supernatant fluid. Irradiation and 
sonication may disrupt this complex making it unrecognizable 
to the sensitized lymphocytes. 
The Jensen tumor system would seem to of fer several 
advantages in studies concerning immunological mechanisms. 
The system is easy to maintain both in vivo and in vitro. 
It, also, is very tumorigenic. Transplants are successful 
in over 90% of the animals challenged and lead to the demise 
of 80% of these animals. The fact that the tumor is 
.. 
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allogeneic a.nd still :is only rejected by 20% of the animals 
presents a stimulating question on the mechanism(s) involved 
in tumor success. In this system the cytotoxic lymphocyte 
response was higho Many animals gave 100 percent cytotoxicity 
indices at 21 days after tu.mar challenge .. These findings 
resolve the question as to whether or not the visual cyto-
toxici ty assay (used in this paper) only measured inhibition 
of growth and not cell lysis. Rat lymphocytes can be easily 
obtained £ram lymphoid organs or peripheral blood by cardiac 
puncture. These cells are relatively stable in vitro 
offering another advantage of this tumor model. 
The immunological parameters of the Jensen system 
have been describ~d. It is our opinion that further studies 
with this system will offer insight into the mechanism(s) 
involved in tumor and allograft rejections ·o Since the 
tumor first arose in an outbred population it may be useful 
in trying to bridge the gap between studies of tumors in 
inbred strains of animals and studies in man. 
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